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Abstract
Background: This study was undertaken to evaluate whether steady state concentrations of allopurinol can improve ischemia in 
canine skin flaps. 
Methods: Twenty dogs underwent one skin flap surgery with a 2-week interval. The first procedure was performed according to the 
standard protocols. The second phase was started by a 1-week pretreatment with allopurinol. Length of the necrotic zone was 
measured and recorded daily. At each phase, flaps were removed and sent for histopathological study after 1week observation. 
Results: Mean length of the necrotic zone in allopurinol treated skin flaps has been significantly less than normal flaps over all 7 days 
of observation (p-value<0.0001). Histopathology study showed less inflammation and more normal tissue structure in the allopurinol 
treated skin flaps. 
Conclusions: Findings obtained from our study demonstrate that systemic administration of allopurinol significantly improves skin 
flap survival and may have significant clinical implications.
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Introduction
    Surgeons rely on skin flaps to reconstruct tissue defects resulting 
from trauma, ablative surgery or congenital malformation. Howe- 
er, prolonged tissue ischemia in setting of trauma or prolonged 
procedures can lead to tissue necrosis and eventual demise of the 
skin flap [1, 2]. Despite remarkable progress in plastic surgery over 
the previous two decades, partial flap necrosis has been reported in 
7-20% of free flaps and 20-33% of pedicled flaps [3-9].
Ischemia-reperfusion (IR) injury is one of the most important 
causes of flap damage. IR injury likely results in a complex pathway 
involving neutrophil infiltration and production of superoxide free 
radicals which lead to irreversible tissue damage, need for 
reoperations, prolonged hospitalization and increased medical costs 
[10-14]. 
    Xanthine oxidase (XO) plays an important role in the pathogen- 
esis of IR injury. There is a significant up-regulation of XO system 
during ischemia of skin flaps [15, 16]. XO is a major source of 
reactive oxygen species (ROS) which triggers release of several 
inflammatory mediators [17, 18]. Allopurinol is an antioxidant drug,    
*Address for Correspondence: Kaveh Alizadeh, Division of Plastic and 
reconstructive Surgery, Westchester Medical Center, Vahalla, New York, Tel: 
212.348.0100; Fax: 516.439.5011; Email: drkaveha@gmail.com
Received: February 15, 2017; Date Accepted: March 10th, 2017; Date 
published: March 13, 2017.
and inhibits XO. Hence, systemic administration of allopurinol 
reduces ROS formation and may improve survival rate of skin flaps 
[19, 20]. However, effectiveness of allopurinol in improving skin flap 
survival is still controversial [21, 22].
   Given our understanding of IR and the ongoing controversies about 
the role of Allopurinol in the XO pathway, we set out to design a study 
to further elucidate the steady state concentration level of allopurinol 
required to improve skin flap survival in dogs.
Materials and Methods
   This clinical trial was performed at veterinary research clinic of the 
Isfahan University Medical Centre. The study received IRB approval 
by the University ethics committee (391136) and adhered to the strict 
guidelines of the Helsinki Declaration.
   Twenty male, healthy dogs aged between 3 to 4 years and mean 
weight of 5.4 kg (range 4-6 kg) were included in the present study. All 
dogs had physical examination prior to the study. They had been 
completely vaccinated, and had received a complete course of anti 
parasite medication. All dogs were kept in separate cages during the 
study and were fed with normal diet.
      The subjects were divided into two groups of ten (Group A and B). 
All dogs underwent one skin flap surgery by a single blinded surgeon 
(a total number of 20 skin flaps). Group A (control group) procedure 
was performed under the standard conditions with no additional 
medication.  Group B procedure was performed similar to the first 
one,  but   all   dogs   were   pre-treated   with   unlabeled   use   of  oral 
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Pathologic study of the skin flaps
     One week after each skin flap surgery, the skin flaps were removed, 
fixed in 10% formalin and sent for histopathological study. After 
hematoxylin and eosin (H&E) and toluidine blue staining, all samples 
were investigated by a single pathologist who was unaware of the type 
of treatment. Samples were studied regarding the number of 
neutrophils, fibroblasts, mast cells and other inflammatory cells, using 
a light microscope.
Statistical analysis    
   Data was analyzed by SPSS 16.5 software. Independent-t test was 
used to compare mean length of necrotic zone between standard flaps 
and allopurinol treated flaps.
Results
   Comparison of two types of skin flaps showed that mean total area 
of the necrotic zone in allopurinol treated skin flaps (27.6 Cm²) have 
been significantly less than necrotic area in normal flaps (78 Cm²) 
over all 7 days of observation [Figure 2]. Dogs in the control group 
presented an average of 81.25% of necrosis in the flap total area; those 
which received allopurinol presented an average of 28.75% of necrosis. 
Table 1 illustrates the changes in length of necrotic zone for both 
groups during observation time. Differences in area of necrotic zones 
increased proportionally with observation time (P < 0.05). [Figure 3 
and 4] represent skin flaps treated with allopurinol 3 and 7 days after 
skin flap surgery whereas [Figure 5 and 6] show control group without 
allopurinol treatment 3 and 7 days after skin flap surgery.
allopurinol from one week before the surgery until 48 hours after 
skin flap surgery. 
Group A skin flap surgery
    After 12 hours of fasting, the  surgical  site  (the back of the dogs) 
was shaved. Dogs were anaesthetized with ketamine (75 mg/kg of 
body weight) and a cuffed endotracheal tube was inserted into the 
trachea. Then an island adipofascial cutaneous flap, 4×24 cm, was 
created in one side of the spinal column extending down to the 
fascia. Afterwards, the flap was sutured in place immediately using 
simple interrupted Nylon 1-0 sutures [Figure 1].
 Figure 1: Schematic view of the surgical site and sutures’ sites.
    After the operation dogs were treated with appropriate dose of 
analgesics. In addition, a daily dose of 30 mg/kg Cefazolin was 
commenced intravenously 60 minutes prior and every day after 
surgery. All dogs were visited on a daily basis by a veterinarian and 
the surgeon to check the general condition and skin flap status. At 
the end of this one-week observation flaps were removed. After 
removal, flap site was closed with simple continuous suture of 
nylon-01. 
Group B skin flap surgery
 All ten dogs in second group received allopurinol (MD-Allop-  
urinol ® 100 mg, Mehr Darou, Tehran, Iran, daily dose of 50 mg/kg 
of body weight) through the nasogastric tube for 9 days (7 days prior 
to surgery, 2 days during the observation). Skin flap surgery was 
performed one week after commencing allopurinol. Otherwise, the 
second operation was completely similar to the first group one. 
Measurements
    All flaps were assessed daily regarding the size of the necrotic area. 
Surface of the necrotic area was measured by the surgeon in-vivo, 
using a single standard ruler with the accuracy of 1/10 centimeter. All 
measurements were recorded in cm2. Length of the necrotic zone was 
defined as the longest distance between the necrotic edge and the 
survived area. Care was taken to ensure maintenance of a straight line 
during the measurement.
Figure 2: Illustration of changes in the mean area of necrotic zone in both 
groups. Data are presented as mean area of necrotic zone in cm2 in different 
days.
Figure 3:  Postoperative view on allopurinol treated dog 3 days after skin flap 
surgery.
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Figure 4: Vital flap mainly supplied by the basis allocated in allopurinol treated 
group 7 days after skin flap surgery.
Figure 5: About two thirds of the base distant flap outlined to be necrotic 
without any allopurinol administration 3 days after skin flap surgery.
Figure 6: Insufficiently perfused flap of control group without any allopurinol 
treatment 7 days after skin flap surgery.
Figure 7: Histopathological findings of different zones of normal skin flap 7 
days after skin flap surgery. A: necrotic zone, B: transitional zone, C: intact 
zone.
Allopurinol treated skin flaps findings of different zones
1. Necrotic zone findings: Shedding  of the csuperficial epidermis.
Intensive infiltration of inflammatory cells - neutrophils and
macrophage - around the muscle bundles with focal microabsc- 
ess and dilated vessels and thrombosis in some of them [Figure
8a,b].
2. Transitional zone findings: Focal shedding of the epidermis acc- 
ompanied by mild infiltration of neutrophils. Obvious red blood
cell extravasation in superficial dermis. Severe panniculitis, fat
necrosis, infiltration of neutrophils and dilated vessels with
some thrombosis were seen in the deep dermis [Figure 8c].
3. Intact zone  findings: Completely  normal  structure of  the  skin
tissue [Figure 8d].
1. Necrotic zone findings: Coagulative necrosis with large  amou- 
nts of vessel thrombosis can be detected. A few neutrophils and
fibrotic tissue in margins were seen [Figure 7a].
2. Transitional zone findings: Destruction of the epidermis in
most of the regions. In superficial dermis there was infiltration
of inflammatory cells - mostly neutrophils - between collagen
bundles. Existing microabscess. More severe inflammation was
found in the subcutis fat in form of non-septal panniculitis. Fat
necrosis with intensive infiltration of inflammatory cells -
neutrophils, macrophage and lymphoplasma cells could be
detected. Numerous dilated vessels with evidence of thrombosis
in some of them were present [Figure 7b].
3. Intact zone findings: Moderate infiltration of inflammatory cells
- macrophage and plasma cells - in the subcutaneous fat and
deep dermis. There was focal fat necrosis. Furthermore, existing
extravasation of red blood cells and vasodilatation [Figure 7c].
Normal skin flaps findings of different zones
Table 1: Comparison of mean length of necrotic zone between two types of 
flaps in different days. Data are presented as mean (±SD) length of the necrotic 
zone, in cm, during the  observation time. N = number of cases; SD = standard 
deviation.
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Mean length of the necrotic zone (cm) 
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 
Normal skin 
flaps (n=10) 




2.4±0.3 3.2±0.4 3.9±0.5 4.4±0.6 5.0±0.6 5.5±0.6 5.8±0.6 
p-value <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 <0.0001 
Figure 8: Histopathological findings of different zones of allopurinol treated 
skin flap 7 days after skin flap surgery. A,B: necrotic zone: shedding of the 
superficial epidermis (arrow) with infiltration of inflammatory cells. C: 
transitional zone: mild infiltration of neutrophils. Obvious red blood cell 
extravasation in superficial dermis (arrow), infiltration of neutrophils and 
dilated vessels with some thrombosis (arrow head), D: intact zone.
Discussion
  Despite several treatment strategies which aim at reducing or 
preventing skin flap necrosis, improvement of the flap survival is still 
an important concern for surgeons. This study showed that pre- and 
post-treatment with allopurinol leads to significant reduction of the 
necrotic zone length, more normal histological structure and less 
inflammation of the skin tissue in dogs.
     Allopurinol has been primarily used for treatment of hyperuricemia 
and gout [23], but based on its mechanism of action and its effects on 
endothelial function, it has been investigated as a novel medication for 
other medical problems [24-27]. Effects of allopurinol on survival of 
skin flaps are related to its mechanism of action and mechanisms 
which cause tissue damage [28].
    ROS including oxygen ions, free radicals and peroxides are gener- 
ated during ischemic phase and especially during reperfusion. The 
production of ROS over the reperfusion phase results in endothelial 
cell swelling, vasoconstriction and increased capillary permeability 
which impairs the microcirculation [20, 29]. ROS are usually produced 
by two major mechanisms: The Nicotinamide Adenine Dinucleotide 
Phosphate (NADPH) oxidase system in neutrophils and the XO 
system in endothelium cells [12, 30, 31]. The XO system appears to be 
a major source of ROS [12, 32-34]. The activity of this system 
significantly increases during the ischemia, and produces a large 
amount of ROS [20]. Therefore, it is not surprising to find that 
systemic administration of an XO inhibitor such as allopurinol 
improves skin flap survival.
    A previous study performed by Tamir et al. confirms our findings 
by a different study design in rats. They investigated effects of 
allopurinol on survival of island skin grafts under prolonged period of 
ischemia and found it a useful method to improve skin flap survival 
[28]. They believe that pre-treatment with allopurinol enables skin 
grafts to tolerate longer periods of  ischemia. This  effect is contributed 
to the XO inhibitor properties of allopurinol. Another study by Im 
et al. also reported that allopurinol can improve skin flap survival in 
rats by inhibiting most of the increased activity of XO during IR, 
and consequently, by preventing tissue damage [35].
    Picard-Ami et al. reported different levels of XO activity in rats, 
pigs and humans [36]. Therefore, in contrast to the above mentioned 
studies, they studied effects of allopurinol on skin flaps of pigs and 
found it ineffective [22]. This finding shows that although allopurinol 
can improve skin flap survival by reducing ROS levels, this effect is 
completely dependent on the level of XO activity in the target organ.
      Even though critical flap monitoring is within 72 hours postopera- 
tively [37], we did monitor the flaps over 1 week. Nevertheless, our 
study lacks an extended observation period and thus no statement can 
be made regarding long-term survival. The present experiment had 
some critical differences with aforementioned studies. Instead of 
rats which are most commonly used to investigate this subject, we 
used dogs. Accordingly, flaps dimensions can be dissected similar to 
possible human correlates and there is no size limitation like rats, also 
we chose to focus on dogs because we wanted to show the difference 
in a setting where the surface area of flaps raised would be similar to 
clinical scenarios in humans and the dog model was the closest 
animal that would be able to provide. More importantly, in contrast 
to the previous studies in which allopurinol was administrated a few 
hours before [22] or even after the procedure [28],  in this study dogs 
were pre-treated with allopurinol for 1 week prior to the surgery 
which helped us to reach a steady plasma concentration of the drug. 
    In summary, findings obtained from our study demonstrated that 
systemic administration of allopurinol significantly improved skin 
flap survival and had a protective effect against flap necrosis in dogs. 
Clinical impressions were confirmed by histopathological examina- 
tion. 
  Although results of this method regarding administration of 
allopurinol are promising, further studies such as comparison of XO 
activity of dogs with humans are required prior to apply it on 
humans. Furthermore, studies with even smaller dimensioned flaps 
and longer timelines should be planned. It would be of utmost 
interest to find clinical patients who are managed on Allopurinol for 
other medical conditions and see whether they respond better to flap 
surgery using in vivo vascular studies. 
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